Literature DB >> 35432780

Human papillomavirus prevalence in oral and oropharyngeal squamous cell carcinoma in South America: A systematic review and meta-analysis.

Antônio Carlos Oliveira1, Israel Carlos Cavalcanti de Lima1, Vitor Marcelo Frez Marques1, Wudson Henrique Alves de Araújo1, Chrystiano de Campos Ferreira2.   

Abstract

Some studies have addressed the prevalence of human papillomavirus (HPV) in head and neck cancer in South America; however, no studies have systematically gathered prevalence and conducted a meta-analysis. This study aims to estimate the prevalence of HPV in oral and oropharyngeal squamous cell carcinomas in South America. We performed a systematic review and metaanalysis using the following databases: PubMed, Embase, Lilacs, Medline, Scopus, and Web of Science. Data were extracted and analyzed using random-effects models to estimate the pooled prevalence of HPV. We identified 209 nonduplicated studies, of which 38 were selected. The overall prevalence of HPV was 24.31% (95% CI 16.87-32.64; I2 = 96%, p heterogeneity <0.001). HPV prevalence in oropharyngeal cancer was 17.9% (95% CI 7.6-31.4; I2 = 96%, p heterogeneity <0.001) and that in oral cavity cancer was 23.19% (95% CI 14.94-32.63; I2 = 94%, p heterogeneity <0.001). We found an overall prevalence of HPV in 24.31% of oral and oropharyngeal squamous cell carcinomas in South American patients. The prevalence of HPV was 17.9% for oropharyngeal cancer and 23.19% for oral cavity cancer. ©Copyright: the Author(s).

Entities:  

Keywords:  Squamous cell carcinoma of head and neck; meta-analysis; oral cavity squamous cell carcinoma; oropharyngeal squamous cell carcinoma; prevalence

Year:  2022        PMID: 35432780      PMCID: PMC9012143          DOI: 10.4081/oncol.2022.552

Source DB:  PubMed          Journal:  Oncol Rev        ISSN: 1970-5557


  48 in total

Review 1.  Prevalence of Human Papillomavirus in Oropharyngeal Cancer: A Systematic Review.

Authors:  Andrew P Stein; Sandeep Saha; Jennifer L Kraninger; Adam D Swick; Menggang Yu; Paul F Lambert; Randall J Kimple
Journal:  Cancer J       Date:  2015 May-Jun       Impact factor: 3.360

Review 2.  Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.

Authors:  Elena-Sophie Prigge; Marc Arbyn; Magnus von Knebel Doeberitz; Miriam Reuschenbach
Journal:  Int J Cancer       Date:  2016-12-02       Impact factor: 7.396

3.  BUBR1 expression in benign oral lesions and squamous cell carcinomas: correlation with human papillomavirus.

Authors:  Régia C P Lira; Fabiana A Miranda; Márcia C M Guimarães; Renata T Simões; Eduardo A Donadi; Christiane P Soares; Edson G Soares
Journal:  Oncol Rep       Date:  2010-04       Impact factor: 3.906

4.  Oral squamous cell carcinoma versus oral verrucous carcinoma: an approach to cellular proliferation and negative relation to human papillomavirus (HPV).

Authors:  José Vieira de Spíndula-Filho; Aparecido Divino da Cruz; Angélica Ferreira Oton-Leite; Aline Carvalho Batista; Cláudio Rodrigues Leles; Rita de Cássia Gonçalves Alencar; Vera Aparecida Saddi; Elismauro Francisco Mendonça
Journal:  Tumour Biol       Date:  2010-12-07

5.  Human papillomavirus in tonsillar squamous cell carcinomas from Guatemala and Brazil.

Authors:  Alicia Rumayor Piña; Laísa Simakawa Jimenez; Fernanda Viviane Mariano; Bruno Augusto Benevenuto de Andrade; Román Carlos; Albina Altemani; Oslei Paes de Almeida
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2015-12-19

6.  Prevalence of human papillomavirus in squamous cell carcinoma of the tongue.

Authors:  Carlos Eduardo Xavier dos Santos Ribeiro da Silva; Ismael Dale Cotrim Guerreiro da Silva; Artur Cerri; Luc Louis Maurice Weckx
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2007-07-25

7.  Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.

Authors:  Rossana Verónica Mendoza López; José Eduardo Levi; José Eluf-Neto; Rosalina Jorge Koifman; Sergio Koifman; Maria Paula Curado; Pedro Michaluart-Junior; David Livingstone Alves Figueiredo; Fabiano Pinto Saggioro; Marcos Brasilino de Carvalho; Luiz Paulo Kowalski; Márcio Abrahão; Francisco de Góis-Filho; Eloiza Helena Tajara; Tim Waterboer; Paolo Boffetta; Paul Brennan; Victor Wünsch-Filho
Journal:  Cancer Causes Control       Date:  2014-01-29       Impact factor: 2.506

8.  Detection of HPV in mouth floor squamous cell carcinoma and its correlation with clinicopathologic variables, risk factors and survival.

Authors:  L E Simonato; J F Garcia; M L M M Sundefeld; N J Mattar; L A Veronese; G I Miyahara
Journal:  J Oral Pathol Med       Date:  2008-11       Impact factor: 4.253

9.  Hpv impact on oropharyngeal cancer patients treated at the largest cancer center from Brazil.

Authors:  Luisa Aguirre Buexm; Sheila Coelho Soares-Lima; Paul Brennan; Priscila Valverde Fernandes; Monique de Souza Almeida Lopes; Flávia Nascimento de Carvalho; Izabella Costa Santos; Luiz Fernando Dias; Simone de Queiroz Chaves Lourenço; Luis Felipe Ribeiro Pinto
Journal:  Cancer Lett       Date:  2020-02-19       Impact factor: 8.679

10.  Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer.

Authors:  Devasena Anantharaman; Behnoush Abedi-Ardekani; Daniel C Beachler; Tarik Gheit; Andrew F Olshan; Kathy Wisniewski; Victor Wunsch-Filho; Tatiana N Toporcov; Eloiza H Tajara; José Eduardo Levi; Raquel A Moyses; Stefania Boccia; Gabriella Cadoni; Guido Rindi; Wolfgang Ahrens; Franco Merletti; David I Conway; Sylvia Wright; Christine Carreira; Helene Renard; Priscilia Chopard; Sandrine McKay-Chopin; Ghislaine Scelo; Massimo Tommasino; Paul Brennan; Gypsyamber D'Souza
Journal:  Int J Cancer       Date:  2017-02-14       Impact factor: 7.396

View more
  1 in total

1.  Human Papillomavirus Detected in Oropharyngeal Cancers from Chilean Subjects.

Authors:  Carolina Oliva; Diego Carrillo-Beltrán; Paul Boettiger; Iván Gallegos; Francisco Aguayo
Journal:  Viruses       Date:  2022-06-02       Impact factor: 5.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.